Skip to main content
RecallFDAfda-F-1146-2018UNDECLARED ALLERGEN

Cinnamon Sugar Cookie, Brand name Columbia Gorge Gluten Free. Packaged in a plastic bag for wholesale purposes. The product is receive...

Units Affected
4
Recall Date
April 10, 2018
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1146-2018.

Cinnamon Sugar Cookie is recalled because the ingredient statement declared milk but the Contains statement declared only Dairy.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1146-2018.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Columbia Gorge Gluten Free or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1146-2018.

Columbia Gorge Gluten Free

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Columbia Gorge Gluten Free Recall FAQ

Columbia Gorge Gluten Free is the subject of a bakery & grains safety report: Cinnamon Sugar Cookie, Brand name Columbia Gorge Gluten Free. Packaged in a plastic bag for wholesale purposes. The product is receive.... The notice was published on April 10, 2018 by the U.S. Food and Drug Administration (FDA). Approximately 4 units are potentially affected.